PISCATAWAY, N.J., June 3, 2020 /PRNewswire/ -- GenScript Biotech Corp., the world's leading research reagent provider, announced today that the company has filed for Emergency Use Authorization (EUA) ...
GenScript Biotech Corporation announced that the US Patent and Trademark Office (USPTO) have issued a notice of allowance for a patent application covering a novel Surrogate Virus Neutralization Test ...
LEIDEN, Netherlands & BILBAO, Spain--(BUSINESS WIRE)--GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading ...
PISCATAWAY, N.J., July 28, 2021 /PRNewswire/ — GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, ...
GenScript's latest at-home rapid test is designed to help individuals make better health decisions regarding SARS-CoV-2 exposure; it detects neutralizing antibodies in patients who have either been ...
GenScript’s new DNA Encoded Chemical Library (DECL) kit will revolutionize your pharmaceutical hit discovery and chemical biology research. In partnership with a leading technology expert, GenScript ...
Exclusive agreement for region brings GenScript's innovative cPass™ kit to Spain, Portugal and Andorra GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation ("GenScript", ...
LEIDEN, Netherlands & BILBAO, Spain–(BUSINESS WIRE)–GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a world-leading biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results